These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1191471)

  • 41. I. v. suxamethonium test.
    Plötz J; Schreiber W
    Br J Anaesth; 1982 Apr; 54(4):475-6. PubMed ID: 7066146
    [No Abstract]   [Full Text] [Related]  

  • 42. Muscle relaxants--suxamethonium and THA.
    Ball C; Westhorpe RN
    Anaesth Intensive Care; 2006 Feb; 34(1):3. PubMed ID: 16494142
    [No Abstract]   [Full Text] [Related]  

  • 43. Tetrahydroaminoacridine. Clinical use of a cholinesterase inhibitor in conjunction with succinylcholine.
    BENVENISTE D; DYRBERG V
    Acta Anaesthesiol Scand; 1962; 6():1-6. PubMed ID: 13867402
    [No Abstract]   [Full Text] [Related]  

  • 44. Proceedings: A trans-atlantic comparison of the pharmacokinetics of suxamethonium.
    Norman J
    Br J Anaesth; 1976 Aug; 48(8):814. PubMed ID: 947351
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of tetraethylammonium (TEA) and temperature on the neuromuscular block produced by magnesium.
    STOVNER J
    Acta Physiol Scand; 1957 Dec; 41(4):370-83. PubMed ID: 13497782
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of neostigmine on the duration of action of suxamethonium in the dog.
    Jones RS; Heckmann R; Wuersch W
    Br Vet J; 1980; 136(1):71-3. PubMed ID: 7363051
    [No Abstract]   [Full Text] [Related]  

  • 47. NEW DERIVATIVES OF 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE.
    BRIAN WP; SOUTHER BL
    J Med Chem; 1965 Jan; 8():143-4. PubMed ID: 14287256
    [No Abstract]   [Full Text] [Related]  

  • 48. The acute intravenous toxicity of tetrahydroaminoacridine.
    VAN DE WAL A
    Tech Rep CRDLR US Army Chem Res Dev Lab; 1961 Jan; 3042():1-13. PubMed ID: 24545952
    [No Abstract]   [Full Text] [Related]  

  • 49. Estimation and urinary excretion of tetrahydroaminoacridine.
    KAUL PN
    J Pharm Pharmacol; 1962 Apr; 14():237-42. PubMed ID: 14454487
    [No Abstract]   [Full Text] [Related]  

  • 50. Goodbye suxamethonium!
    Lee C
    Anaesthesia; 2009 Mar; 64 Suppl 1():73-81. PubMed ID: 19222434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tacrine-suxamethonium apnea in patients with hepatosplenic schistosomiasis.
    El-Hawary KA; Atallah MM; Hussein SM; El-Bana MH; Wafa AM
    Middle East J Anaesthesiol; 1980 Oct; 5(8):523-7. PubMed ID: 7253943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical and clinical study for the role of tacrine as succinylcholine extender.
    el-Kammah BM; el-Gafi SH; el-Sherbiny AM; Kader MM
    J Egypt Med Assoc; 1975; 58(9-10):559-67. PubMed ID: 1236674
    [No Abstract]   [Full Text] [Related]  

  • 53. Dual block following tacrine and suxamethonium.
    Macdonald DJ
    Br J Anaesth; 1967 Aug; 39(8):629-32. PubMed ID: 6035131
    [No Abstract]   [Full Text] [Related]  

  • 54. Suxamethonium apnoea masked by tetrahydroaminacrine.
    Lindsay PA; Lumley J
    Anaesthesia; 1978; 33(7):620-2. PubMed ID: 686334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proceedings: The effect of tacrine on the neuromuscular block produced by suxamethonium in man.
    Norman J; Morgan M
    Br J Anaesth; 1975 Sep; 47(9):1027. PubMed ID: 1191471
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.